China SXT Pharmaceuticals (SXTC) Enterprise Value (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Enterprise Value of -$28.2 million for Q1 2026, down 55.16% year-over-year from -$62.8 million in Q1 2025, and down 32.92% quarter-over-quarter from -$21.2 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Enterprise Value (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Enterprise Value history runs 9 years deep, the most recent figure standing at -$28.2 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 55.16% year-over-year to -$28.2 million; the TTM figure through Mar 2026 stood at -$28.2 million (down 55.16% YoY), while the FY2026 annual figure was -$28.2 million, down 55.16% from the prior year.
- Enterprise Value for Q1 2026 stood at -$28.2 million, down from -$21.2 million in the prior quarter.
- The five-year high for Enterprise Value was -$12.1 million in Q1 2024, with the low at -$28.2 million in Q1 2026.
- The 5-year median for Enterprise Value is -$17.4 million (2023), against an average of -$18.2 million.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value jumped 30.43% in 2024, then slumped 55.16% in 2026.
- China SXT Pharmaceuticals' Enterprise Value stood at -$15.6 million in 2022, then slipped by 11.55% to -$17.4 million in 2023, then dropped by 6.59% to -$18.5 million in 2024, then dropped by 14.5% to -$21.2 million in 2025, then tumbled by 32.92% to -$28.2 million in 2026.
- Business Quant data shows SXTC's Enterprise Value at -$28.2 million in Q1 2026, -$21.2 million in Q3 2025, and -$18.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - | -28.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.18 Mn |
| Sep 30, 2025 | -21.20 Mn |
| Mar 31, 2025 | -18.16 Mn |
| Sep 30, 2024 | -18.51 Mn |
| Mar 31, 2024 | -12.08 Mn |
| Sep 30, 2023 | -17.37 Mn |
| Mar 31, 2023 | -17.37 Mn |
| Sep 30, 2022 | -15.57 Mn |
| Mar 31, 2022 | -15.61 Mn |
| Sep 30, 2021 | -13.36 Mn |
| Mar 31, 2021 | -13.38 Mn |
| Sep 30, 2020 | -10.35 Mn |
| Mar 31, 2020 | -7.29 Mn |
| Sep 30, 2019 | -9.37 Mn |
| Mar 31, 2019 | -9.45 Mn |
| Sep 30, 2018 | -565,809.00 |
| Mar 31, 2018 | -755,282.00 |